2020-05-31T17:31:54Z
2020-05-31T17:31:54Z
2019-12
2020-05-31T17:31:54Z
Neuroendocrine tumours (NETs) are rare malignancies characterised by its capacity to synthesise and secrete monoamines, due to its neuroendocrine origin. Its varied locations and symptoms have traditionally been responsible for extended delays in their diagnosis. The interest of this study was to characterise the patient population diagnosed with NETs in Spain and to revise how the disease is managed, together with the hospitalisation costs of these patients. (...)
Article
Published version
English
Neurologia; Endocrinologia; Epidemiologia; Neurology; Endocrinology; Epidemiology
BioMed Central
Reproducció del document publicat a: https://doi.org/10.1186/s12885-019-6412-8
BMC Cancer, 2019, vol. 19, num. 1226, p. 01-07
https://doi.org/10.1186/s12885-019-6412-8
cc-by (c) Darbà, Josep et al., 2019
http://creativecommons.org/licenses/by/3.0/es
Economia [1045]